Search company, investor...

Predict your next investment

Private Equity
cobroventures.com

Investments

13

Portfolio Exits

2

Funds

1

About Cobro Ventures

Cobro Ventures is a management company that encompasses a diversified portfolio of investments. The firm's investments range from new start-ups to enterprises that have become public and been acquired.

Headquarters Location

Washington, DC,

United States

Want to inform investors similar to Cobro Ventures about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Cobro Ventures News

AI Proteins Raises $18.2M In Seed Funding

Nov 7, 2022

November 7, 2022 The round was led by Cobro Ventures and Lightchain Capital. The company intends to use the funds to expand operations and its business reach. Led by CEO Drew Dennison and founder, President, and CSO Dr. Chris Bahl, AI Proteins is using its de novo protein design platform to unlock the therapeutic potential of miniproteins, which are peptides that form a hyperstable three-dimensional structure. Miniproteins can solve many issues facing traditional antibody development, acting to drive down costs, speed up therapeutic development, and improve success rates.

Cobro Ventures Investments

13 Investments

Cobro Ventures has made 13 investments. Their latest investment was in Angiocrine Bioscience as part of their Series B on March 3, 2022.

CBI Logo

Cobro Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/29/2022

Series B

Angiocrine Bioscience

Yes

Cobro Ventures, and Undisclosed Investors

1

2/9/2022

Series B

Regenacy Pharmaceuticals

$9.3M

No

2

1/27/2022

Series A

NextRNA Therapeutics

$46.8M

Yes

2

1/25/2022

Series B - II

Subscribe to see more

$99M

Subscribe to see more

10

1/21/2022

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/29/2022

2/9/2022

1/27/2022

1/25/2022

1/21/2022

Round

Series B

Series B

Series A

Series B - II

Seed VC

Company

Angiocrine Bioscience

Regenacy Pharmaceuticals

NextRNA Therapeutics

Subscribe to see more

Subscribe to see more

Amount

$9.3M

$46.8M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Cobro Ventures, and Undisclosed Investors

Sources

1

2

2

10

10

Cobro Ventures Portfolio Exits

2 Portfolio Exits

Cobro Ventures has 2 portfolio exits. Their latest portfolio exit was C4 Therapeutics on October 02, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/2/2020

IPO

$99M

Public

2

10/3/2019

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/2/2020

10/3/2019

Exit

IPO

IPO

Companies

Subscribe to see more

Valuation

$99M

$99M

Acquirer

Public

Subscribe to see more

Sources

2

10

Cobro Ventures Fund History

1 Fund History

Cobro Ventures has 1 fund, including Cobro Ventures Opportunity Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

Cobro Ventures Opportunity Fund

1

Closing Date

Fund

Cobro Ventures Opportunity Fund

Fund Type

Status

Amount

Sources

1

Cobro Ventures Team

6 Team Members

Cobro Ventures has 6 team members, including current Founder, Chief Executive Officer, Marc A. Cohen.

Name

Work History

Title

Status

Marc A. Cohen

Founder, Chief Executive Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Marc A. Cohen

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Founder, Chief Executive Officer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.